Evaluates antioxidative properties of boron compounds in psoriasis model, suggesting therapeutic potential.
Objectives: Psoriasis is a chronic inflammatory skin disorder that substantially affects patients’ quality of life. Oxidative stress arises when there is a disruption in the balance between reactive oxygen species (ROS) and the body's antioxidant defense mechanisms, significantly contributing to its pathophysiology. This study aimed to investigate the effects of various boron compounds—borax, colemanite, boric acid, and ulexite—on oxidative stress markers in an LPS-induced psoriasis-like cell culture model using HaCaT keratinocytes.Methods: HaCaT cells were stimulated with LPS to induce a psoriasis-mimicking inflammatory response. Subsequently, cells were treated with different boron compounds. To evaluate antioxidant activity and lipid peroxidation, oxidative stress markers such as superoxide dismutase (SOD), glutathione peroxidase (GPx), and malondialdehyde (MDA) were examined.Results: Boron compounds modulated oxidative stress parameters by enhancing SOD and GPx activities and reducing lipid peroxidation, as reflected by decreased MDA levels. Among the tested agents, colemanite and ulexite exhibited the strongest antioxidant activities, likely attributable to their distinct mineral compositions.Conclusion: Findings suggest that boron compounds hold therapeutic potential for reducing oxidative stress in psoriasis-like conditions. Further research is needed to clarify the underlying molecular mechanisms and to refine boron-based therapeutic applications.
No takes yet. Share an insight, caveat, or question.
Urgancı et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: